Learn how the FDA's 180-day exclusivity works for generic drug applicants, including Paragraph IV certifications, forfeiture risks, and upcoming regulatory changes.
Dec, 7 2025
Aug, 27 2026
Aug, 7 2026
Aug, 11 2025
Jul, 3 2026